When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Gemphire Therapeutics' (NASDAQ:GEMP) stockholders have approved all of the NeuroBo merger-related proposals, including: (i) the issuance of Gemphire common stock pursuant to the Agreement dated July 24, (ii) a reverse stock split of Gemphire common stock, at a ratio of one new share for every 15 to 25 shares outstanding and (iii) changing the name from “Gemphire Therapeutics” to “NeuroBo Pharmaceuticals, Inc.”
More news on: Gemphire Therapeutics Inc., Healthcare stocks news,